New stainless steel access interlock prevents accidental lock-in in dangerous areas
SERV Trayvou Interverrouillage (STI) has launched the NXO1LTC, a new access interlock with personnel key for harsh or corrosive environments
To gain access to a dangerous area, the operator has to first insert an isolation key into the lock portion. Turning this key releases the personnel key, and allows the bolt to be removed and the door opened.
The operator retains the personnel key while inside the dangerous area. This prevents the door being shut behind them and also stops the machine from being restarted by another person.
The NXO1LTC’s completely stainless steel construction makes it suitable for use in harsh or corrosive environments as the paper, food, robotic, chemical and petrochemical industries.
As an entirely mechanical proposition, the NXO1LTC removes the need for cabling, reducing related maintenance costs and eliminating the risk of a cable malfunction.
STI’s safety products are heavy-duty and comply with all European machinery directives currently in force. They are popular with customers due to their strength and simple method of operation.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Taking biologic therapies out of the clinic
Read moreHow larger autoinjectors are changing drug delivery device testing
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny
The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Manufacturing
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Packaging
Embracing healthcare innovation with 2D codes
Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strategic Manager for Digital Coding at Domino Printing Sciences
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.